Angel Biotechnology will provide pre-GMP services for Pathfinder Cell Therapy's novel cell therapy. Additionally, the company has raised £1.9m in a placing of 553,435,720 ordinary shares.
Angel Biotechnology
Angel Biotechnology
Monday, 31 January 2011
New contract as Angel raises cash
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment